Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial
Heise T, Mari A, DeVries JH, et al.
Lancet Diabetes Endocrinol. 2022;10(6):418-429.
Leggi


